Literature DB >> 24872413

High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.

Jie Wu1, Sol Kim2, Man Sup Kwak2, Jang Bin Jeong3, Hyun Jin Min3, Ho-Geun Yoon4, Jin-Hyun Ahn5, Jeon-Soo Shin6.   

Abstract

High mobility group nucleosomal binding domain 2 (HMGN2) is a small and unique non-histone protein that has many functions in a variety of cellular processes, including regulation of chromatin structure, transcription, and DNA repair. In addition, it may have other roles in antimicrobial activity, cell homing, and regulating cytokine release. Although the biochemical properties of HMGN2 protein are regulated by acetylation and phosphorylation, it is not yet known whether HMGN2 activity can also be regulated by SUMOylation. In this study, we demonstrated for the first time that HMGN2 is modified by covalent attachment of small ubiquitin-related modifier 1 (SUMO1) by pro-inflammatory signal and identified the major SUMOylated lysine residues that localize to the HMGN2 nucleosome-binding domain at Lys-17 and Lys-35. SENP1 can deSUMOylate SUMOylated HMGN2, and PIAS1 is the E3 ligase responsible for SUMOylation of HMGN2. Finally, using SUMO1-conjugated HMGN2 purified from a basal SUMOylation system in Escherichia coli, we demonstrated that SUMOylated HMGN2 has decreased the binding affinity to nucleosome core particles in comparison to unSUMOylated HMGN2. These observations potentially provide new perspectives for understanding the functions of HMGN2 in inflammatory reaction.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Chromatin Regulation; HMGN2; Inflammation; Molecular Cell Biology; Nucleosome; Sumoylation

Mesh:

Substances:

Year:  2014        PMID: 24872413      PMCID: PMC4106318          DOI: 10.1074/jbc.M114.555425

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Chromatin unfolding and activation by HMGN(*) chromosomal proteins.

Authors:  M Bustin
Journal:  Trends Biochem Sci       Date:  2001-07       Impact factor: 13.807

2.  Mitotic phosphorylation prevents the binding of HMGN proteins to chromatin.

Authors:  M Prymakowska-Bosak; T Misteli; J E Herrera; H Shirakawa; Y Birger; S Garfield; M Bustin
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

Review 3.  HMGB1 as a late mediator of lethal systemic inflammation.

Authors:  H Wang; H Yang; C J Czura; A E Sama; K J Tracey
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

Review 4.  Studying protein dynamics in living cells.

Authors:  J Lippincott-Schwartz; E Snapp; A Kenworthy
Journal:  Nat Rev Mol Cell Biol       Date:  2001-06       Impact factor: 94.444

Review 5.  HMGN dynamics and chromatin function.

Authors:  Frédéric Catez; Jae-Hwan Lim; Robert Hock; Yuri V Postnikov; Michael Bustin
Journal:  Biochem Cell Biol       Date:  2003-06       Impact factor: 3.626

6.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.

Authors:  Tiziana Bonaldi; Fabio Talamo; Paola Scaffidi; Denise Ferrera; Annalisa Porto; Angela Bachi; Anna Rubartelli; Alessandra Agresti; Marco E Bianchi
Journal:  EMBO J       Date:  2003-10-15       Impact factor: 11.598

7.  Measurement of dynamic protein binding to chromatin in vivo, using photobleaching microscopy.

Authors:  Robert D Phair; Stanislaw A Gorski; Tom Misteli
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

8.  Specific acetylation of chromosomal protein HMG-17 by PCAF alters its interaction with nucleosomes.

Authors:  J E Herrera; K Sakaguchi; M Bergel; L Trieschmann; Y Nakatani; M Bustin
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

9.  Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3.

Authors:  H Saitoh; J Hinchey
Journal:  J Biol Chem       Date:  2000-03-03       Impact factor: 5.157

10.  Mitotic phosphorylation of chromosomal protein HMGN1 inhibits nuclear import and promotes interaction with 14.3.3 proteins.

Authors:  Marta Prymakowska-Bosak; Robert Hock; Frédéric Catez; Jae-Hwan Lim; Yehudit Birger; Hitoshi Shirakawa; Kyung Lee; Michael Bustin
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more
  6 in total

1.  Evolution of high mobility group nucleosome-binding proteins and its implications for vertebrate chromatin specialization.

Authors:  Rodrigo González-Romero; José M Eirín-López; Juan Ausió
Journal:  Mol Biol Evol       Date:  2014-10-03       Impact factor: 16.240

Review 2.  High Mobility Group Proteins in Sepsis.

Authors:  Guibin Liang; Zhihui He
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

3.  Functional characterization of DnSIZ1, a SIZ/PIAS-type SUMO E3 ligase from Dendrobium.

Authors:  Feng Liu; Xiao Wang; Mengying Su; Mengyuan Yu; Shengchun Zhang; Jianbin Lai; Chengwei Yang; Yaqin Wang
Journal:  BMC Plant Biol       Date:  2015-09-17       Impact factor: 4.215

4.  The modulation of MiR-155 and MiR-23a manipulates Klebsiella pneumoniae Adhesion on Human pulmonary Epithelial cells via Integrin α5β1 Signaling.

Authors:  Yan Teng; Junming Miao; Xiaofei Shen; Xiaolong Yang; Xinyuan Wang; Laibin Ren; Xiaoying Wang; Junli Chen; Jingyu Li; Shanze Chen; Yi Wang; Ning Huang
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

5.  Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1.

Authors:  Christina Paulus; Thomas Harwardt; Bernadette Walter; Andrea Marxreiter; Marion Zenger; Edith Reuschel; Michael M Nevels
Journal:  PLoS Pathog       Date:  2020-05-04       Impact factor: 6.823

6.  Chromatin regulates IL-33 release and extracellular cytokine activity.

Authors:  Jared Travers; Mark Rochman; Cora E Miracle; Jeff E Habel; Michael Brusilovsky; Julie M Caldwell; Jeffrey K Rymer; Marc E Rothenberg
Journal:  Nat Commun       Date:  2018-08-14       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.